| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 16 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 2 | TACROLIMUS OINTMENT 0.1% | 16 |
| 3 | METHOTREXATE | 15 |
| 4 | METHOTREXATE SODIUM | 15 |
| 5 | PREDNISONE | 15 |
| 6 | CYCLOPHOSPHAMIDE | 12 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 9 | MYCOPHENOLATE MOFETIL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | 1 | 0.0345 |
| 1 | INTERLEUKIN-10 | 1 | 0.0028 |
| 2 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 3 | DINUTUXIMAB | 1 | 0.0012 |
| 4 | TREOSULFAN | 3 | 0.0011 |
| 5 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 6 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 7 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 8 | ISAVUCONAZONIUM SULFATE | 2 | 0.0005 |
| 9 | THIOTEPA | 5 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 8 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |